EFG Asset Management North America Corp. reduced its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 13.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 57,920 shares of the company's stock after selling 9,056 shares during the quarter. EFG Asset Management North America Corp.'s holdings in Doximity were worth $3,092,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Global Retirement Partners LLC boosted its position in shares of Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after acquiring an additional 440 shares in the last quarter. UMB Bank n.a. boosted its holdings in shares of Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after purchasing an additional 235 shares in the last quarter. Larson Financial Group LLC increased its stake in shares of Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after purchasing an additional 250 shares during the last quarter. Optimum Investment Advisors acquired a new position in shares of Doximity during the 4th quarter worth $43,000. Finally, Morse Asset Management Inc acquired a new position in shares of Doximity during the 3rd quarter worth $46,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.
Doximity Stock Performance
Shares of NASDAQ:DOCS traded down $2.15 during midday trading on Friday, reaching $58.40. The company's stock had a trading volume of 2,279,418 shares, compared to its average volume of 1,947,026. The firm has a 50 day moving average price of $65.48 and a two-hundred day moving average price of $54.43. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21. The firm has a market capitalization of $10.90 billion, a price-to-earnings ratio of 58.40, a PEG ratio of 4.10 and a beta of 1.34.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on DOCS shares. Leerink Partners upgraded Doximity from a "market perform" rating to an "outperform" rating and lifted their target price for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Piper Sandler upgraded Doximity from a "neutral" rating to an "overweight" rating and increased their price target for the company from $31.00 to $78.00 in a research note on Friday, February 7th. The Goldman Sachs Group boosted their price objective on Doximity from $58.00 to $80.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Bank of America increased their target price on Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a research report on Monday, January 6th. Finally, KeyCorp reduced their price target on Doximity from $70.00 to $65.00 and set an "overweight" rating on the stock in a report on Wednesday, January 8th. Eleven investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $64.22.
Get Our Latest Research Report on DOCS
Insider Buying and Selling at Doximity
In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 37.40% of the company's stock.
Doximity Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Further Reading

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.